Alps Advisors Inc Macrogenics Inc Transaction History

Alps Advisors Inc

$17.2 Billion
Q1 2025

A detailed history of Alps Advisors Inc transactions in Macrogenics Inc stock. As of the latest transaction made, Alps Advisors Inc holds 48,646 shares of MGNX stock, worth $66,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,646

Previous 50,750 4.15%

Holding current value

$66,158

Previous $164,000 62.8%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	SELL	$1.26 - $3.49 $2,651 - $7,342	-2,104 Reduced 4.15%	48,646 $61,000
Q4 2024 Feb 13, 2025	BUY	$3.18 - $4.46 $161,385 - $226,345	50,750 New	50,750 $164,000
Q1 2024 May 14, 2024	BUY	$9.77 - $21.47 $20,302 - $44,614	2,078 Added 4.99%	43,752 $644,000
Q4 2023 Feb 14, 2024	SELL	$4.48 - $10.11 $18,009 - $40,642	-4,020 Reduced 8.8%	41,674 $400,000
Q3 2023 Nov 14, 2023	BUY	$4.48 - $6.19 $1,079 - $1,491	241 Added 0.53%	45,694 $212,000
Q2 2023 Aug 14, 2023	BUY	$4.62 - $7.54 $209,992 - $342,715	45,453 New	45,453 $243,000
Q2 2022 Aug 11, 2022	SELL	$2.25 - $9.99 $141,804 - $629,609	-63,024 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.12 - $16.9 $63,863 - $132,918	-7,865 Reduced 11.09%	63,024 $555,000
Q4 2021 Feb 09, 2022	SELL	$15.91 - $21.88 $63,767 - $87,695	-4,008 Reduced 5.35%	70,889 $1.14 Million
Q3 2021 Nov 15, 2021	SELL	$19.74 - $28.7 $82,513 - $119,966	-4,180 Reduced 5.29%	74,897 $1.57 Million
Q2 2021 Aug 11, 2021	BUY	$20.49 - $35.63 $1.62 Million - $2.82 Million	79,077 New	79,077 $2.12 Million
Q2 2020 Aug 05, 2020	SELL	$5.2 - $29.12 $462,436 - $2.59 Million	-88,930 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$4.28 - $12.11 $44,392 - $125,604	-10,372 Reduced 10.44%	88,930 $518,000
Q4 2019 Feb 07, 2020	BUY	$7.95 - $12.27 $14,429 - $22,270	1,815 Added 1.86%	99,302 $1.08 Million
Q3 2019 Nov 04, 2019	SELL	$12.44 - $17.48 $57,920 - $81,386	-4,656 Reduced 4.56%	97,487 $1.24 Million
Q2 2019 Aug 07, 2019	SELL	$14.51 - $19.71 $220,247 - $299,178	-15,179 Reduced 12.94%	102,143 $1.73 Million
Q1 2019 May 01, 2019	BUY	$11.11 - $25.6 $218,411 - $503,270	19,659 Added 20.13%	117,322 $2.11 Million
Q4 2018 Feb 04, 2019	BUY	$11.75 - $21.42 $269,321 - $490,967	22,921 Added 30.67%	97,663 $1.24 Million
Q3 2018 Oct 25, 2018	BUY	$19.26 - $23.46 $260,010 - $316,710	13,500 Added 22.04%	74,742 $1.6 Million
Q2 2018 Aug 02, 2018	BUY	$19.78 - $24.67 $1.21 Million - $1.51 Million	61,242 New	61,242 $1.27 Million
Q4 2017 Feb 05, 2018	SELL	$16.19 - $20.3 $586,709 - $735,651	-36,239 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$15.52 - $18.94 $562,429 - $686,366	36,239	36,239 $670,000

Others Institutions Holding MGNX

# of Institutions

133

Shares Held

54M

Call Options Held

45.1K

Put Options Held

143K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $83.6M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Macrogenics Inc Transaction History